Filing summary
Business context and reporting period
Smith & Nephew plc filed this Form 6-K on October 8, 2026. The company said it will publish its trading report for the third quarter ended September 26, 2026, on November 4, 2026, at 7:00 a.m. GMT (2:00 a.m. EST), followed by an analyst call at noon GMT (7:00 a.m. EST). The filing is an announcement of the report’s timing, not the quarterly results.
Smith+Nephew describes itself as a medical technology company operating in Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It reports 17,000 employees and operations in more than 100 countries. The filing states annual sales of $6.2 billion for 2025.
Financial metrics and changes
The filing provides no third-quarter revenue, profit, cash flow, margin, debt, liquidity, or other current-period financial results, and no comparison with the prior-year period. It also provides no guidance or outlook for the quarter or full year.
Risks and contingencies
The filing’s forward-looking-statement caution identifies risks including geopolitical conflicts, economic conditions, pricing and competition, regulatory and reimbursement decisions, product quality or recalls, litigation, supply-chain disruption, acquisitions and integration, cybersecurity, climate-related events, taxation, and foreign-exchange volatility. It refers investors to the company’s latest Form 20-F for further discussion.
Important facts for investors to verify
- Review the third-quarter trading report when published on November 4, 2026, for actual performance and comparable-period figures.
- Check the company’s website for analyst-call details and any accompanying presentation or transcript.
- Consult the latest Form 20-F for fuller disclosure of risks and financial information.